Education
About Us
Working with TipRanks
Follow Us
Douglas Alan Hyland Insider Profile
4 Followers
Douglas Alan Hyland, Interim Chief Financial Officer at Rapid Dose Therapeutics Corp, holds 1.60M shares in Rapid Dose Therapeutics Corp (Ticker: TSE:DOSE). Most recently, Douglas Alan Hyland Bought 800,000 shares of Rapid Dose Therapeutics Corp on Aug 28, 2025 for an estimated value of C$16.00K.
Douglas Alan Hyland has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Douglas Alan Hyland's holdings
Insider Roles
Interim Chief Financial Officer
Roles that Douglas Alan Hyland holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Douglas Alan Hyland
Douglas Alan Hyland's Trading History
List of latest transactions for each holding click on a transaction to see Douglas Alan Hyland's performance on stock
You May Also Like
Douglas Alan Hyland insider profile FAQ
What is the percentage of profitable transactions made by Douglas Alan Hyland?
The percentage of profitable transactions made by Douglas Alan Hyland is ―.
What is the average return per transaction made by Douglas Alan Hyland?
The average return per transaction made by Douglas Alan Hyland is ―.
What stocks does Douglas Alan Hyland hold?
Douglas Alan Hyland holds: TSE:DOSE stocks.
What was Douglas Alan Hyland’s latest transaction?
Douglas Alan Hyland latest transaction was an Informative Buy of C$16.00K.
What was Douglas Alan Hyland's most profitable transaction?
Douglas Alan Hyland’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Douglas Alan Hyland's role in Rapid Dose Therapeutics Corp?
Douglas Alan Hyland's role in Rapid Dose Therapeutics Corp is Interim Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.